Treatment patterns and outcomes in patients with nonmetastatic ...

This study aimed to evaluate real-world treatment patterns, utilization and survival outcomes in patients with nmCRPC.

Treatment patterns and outcomes in patients with non-squamous ...

This retrospective observational study provides new insights into treatment patterns,biomarker testing, and outcomes in advanced NSCLC within the context of ...

Treatment patterns and outcomes in patients with non-small cell ...

Amongst non-metastatic patients, radiotherapy was the most frequently observed treatment in first line (32%), followed by chemotherapy (26%), ...

Treatment patterns and outcomes in patients with nonmetastatic ...

Treatment patterns and outcomes in patients with nonmetastatic castration-resistant prostate cancer in the United States. Umang Swami*,a.

Treatment patterns and survival outcomes in patients with non ...

AT improves postoperative survival in localized patients. Surgery after NAT and RCT are the preferred therapeutic options for patients with locally advanced ...

Real-World Clinical Outcomes and Treatment Patterns Among Black ...

Among patients with mCSPC, 65.5% were adherent at 6 months (Black, 64.6%; non-Black, 66.9%), 54.0% at 12 months (Black, 48.9%; non-Black, 56.1%) ...

Treatment patterns and outcomes of patients with metastatic non ...

The landscape of non-small cell lung cancer (NSCLC) therapy is rapidly changing. This analysis aimed to understand patient characteristics, ...

Patient Characteristics, Treatment Patterns, and Outcomes for ...

Over three quarters of patients (78.5% [95% CI: 78.0-78.9]) were alive one year after diagnosis (93.2% in the non-metastatic at diagnosis subgroup and 37.1% ...

Real-World Treatment Patterns and Survival Outcomes for Patients ...

The results from this large, population-based, real-world cohort study provide insights into treatment patterns and outcomes for patients with non-metastatic ...

Treatment patterns and outcomes in metastatic castration-resistant ...

Worse outcomes were observed for mCRPC patients in the BRCA subgroup compared with non-BRCA subgroups, either HRR non-BRCA or non-HRR. Despite ...

Evolution of treatment patterns and survival outcomes in patients ...

Immune checkpoint inhibitors (ICIs) have improved outcomes for patients with advanced non-small cell lung cancer (NSCLC) versus chemotherapy ...

Treatment Patterns and Outcomes in Patients With Metastatic ...

Patients and Methods: We conducted a retrospective, non- interventional cohort analysis of electronic health record data of patients with confirmed mCRPC ...

Real-world treatment patterns and outcomes in patients with HR+ ...

This real-world study describes treatment patterns and outcomes in patients treated with chemotherapy in the United States before approval of antibody–drug ...

Treatment Patterns and Outcomes in Patients With Metastatic ...

Using electronic health record data from the Flatiron Health database, we studied real-world treatment patterns and health outcomes in patients with mCRPC.

Real-world treatment patterns and survival outcomes for patients ...

Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study.

Real-world Treatment Patterns and Associated Outcomes in Patients ...

This is a non-interventional, multi-country, multicentre, retrospective study designed to determine the treatment patterns and associated survival rate in ...

Treatment Patterns and Outcomes in Resected Early-stage Non ...

As the non-small cell lung cancer (NSCLC) adjuvant treatment landscape evolves, an evaluation of treatment patterns and outcomes of patients ...

Treatment patterns and outcomes in patients with nonmetastatic ...

This study aimed to evaluate real-world treatment patterns, utilization and survival outcomes in patients with nmCRPC. Patients & methods ...

Real-world treatment patterns and clinical outcomes in patients with ...

Background:Stage III non-small cell lung cancer (NSCLC) being highly heterogeneous requires multimodal therapeutic strategies for optimal ...

Treatment patterns and survival outcomes for patients with non ...

To report characteristics, treatment and overall survival (OS) trends, by stage and pathology, of patients diagnosed with non-small cell lung cancer (NSCLC)